Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reinke

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Managed Care (Langhorne, Pa.)|October 26, 2017
Otezla, Warts and All, Racks Up Sales and Eyes Blockbuster StatusThomas Reinke
Managed Care (Langhorne, Pa.)|March 30, 2018
Real-World Evidence Not Quite Believable EnoughThomas Reinke
Managed Care (Langhorne, Pa.)|April 28, 2018
Take a Bow, Pharma, for the Hepatitis C DrugsThomas Reinke
Managed Care (Langhorne, Pa.)|May 17, 2017
Biosimilars Ready, At Last, To Make Their Entrance: Stars Are Born or Do They Fizzle?Thomas Reinke
Managed Care (Langhorne, Pa.)|June 30, 2017
Drugs for Diabetes: It's No Longer Just About Controlling Blood SugarThomas Reinke
Managed Care (Langhorne, Pa.)|June 30, 2017
Keytruda Crosses First-Line Finish Line FirstThomas Reinke
Managed Care (Langhorne, Pa.)|June 30, 2017
Real-World Evidence Faces Some Real-World ChallengesThomas Reinke
Managed Care (Langhorne, Pa.)|July 11, 2018
Aimovig for Migraine Prevention: The New Kid May Have Trouble Fitting inThomas Reinke
Managed Care (Langhorne, Pa.)|November 30, 2017
Biosimilars Shake Off Doubters, Go on a RollThomas Reinke
Managed Care (Langhorne, Pa.)|September 13, 2017
After a Big Entrance, It's Just So-So for EntrestoThomas Reinke
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Managed Care (Langhorne, Pa.)|October 26, 2017
Otezla, Warts and All, Racks Up Sales and Eyes Blockbuster StatusThomas Reinke
Managed Care (Langhorne, Pa.)|March 30, 2018
Real-World Evidence Not Quite Believable EnoughThomas Reinke
Managed Care (Langhorne, Pa.)|April 28, 2018
Take a Bow, Pharma, for the Hepatitis C DrugsThomas Reinke
Managed Care (Langhorne, Pa.)|May 17, 2017
Biosimilars Ready, At Last, To Make Their Entrance: Stars Are Born or Do They Fizzle?Thomas Reinke
Managed Care (Langhorne, Pa.)|June 30, 2017
Drugs for Diabetes: It's No Longer Just About Controlling Blood SugarThomas Reinke
Managed Care (Langhorne, Pa.)|June 30, 2017
Keytruda Crosses First-Line Finish Line FirstThomas Reinke
Managed Care (Langhorne, Pa.)|June 30, 2017
Real-World Evidence Faces Some Real-World ChallengesThomas Reinke
Managed Care (Langhorne, Pa.)|July 11, 2018
Aimovig for Migraine Prevention: The New Kid May Have Trouble Fitting inThomas Reinke
Managed Care (Langhorne, Pa.)|November 30, 2017
Biosimilars Shake Off Doubters, Go on a RollThomas Reinke
Managed Care (Langhorne, Pa.)|September 13, 2017
After a Big Entrance, It's Just So-So for EntrestoThomas Reinke
Pageof 4